-
1
-
-
42949171158
-
-
American Cancer Society Atlanta
-
American Cancer Society Global Cancer Facts & Figures 2007 2007 American Cancer Society Atlanta http://www.cancer.org/acs/groups/content/@nho/ documents/document/globalfactsandfigures2007rev2p.pdf
-
(2007)
Global Cancer Facts & Figures 2007
-
-
Cancer Society, A.1
-
2
-
-
1642553649
-
Focus on epithelial ovarian cancer
-
DOI 10.1016/S1535-6108(04)00002-9
-
R.F. Ozols, M.A. Bookman, D.C. Connolly, M.B. Daly, A.K. Godwin, and R.J. Schilder Focus on epithelial ovarian cancer Cancer Cell 5 2004 19 24 (Pubitemid 38121593)
-
(2004)
Cancer Cell
, vol.5
, Issue.1
, pp. 19-24
-
-
Ozols, R.F.1
Bookman, M.A.2
Connolly, D.C.3
Daly, M.B.4
Godwin, A.K.5
Schilder, R.J.6
Xu, X.7
Hamilton, T.C.8
-
3
-
-
33646726747
-
Management of platinum-sensitive recurrent ovarian cancer
-
J. Pfisterer, and J.A. Ledermann Management of platinum-sensitive recurrent ovarian cancer Semin Oncol 33 2 Suppl. 6 2006 S12 S16
-
(2006)
Semin Oncol
, vol.33
, Issue.2 SUPPL. 6
-
-
Pfisterer, J.1
Ledermann, J.A.2
-
4
-
-
0037862963
-
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial
-
M.K. Parmar, J.A. Ledermann, N. Colombo, A. du Bois, J.F. Delaloye, and G.B. Kristensen Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial Lancet 361 2003 2099 2106
-
(2003)
Lancet
, vol.361
, pp. 2099-2106
-
-
Parmar, M.K.1
Ledermann, J.A.2
Colombo, N.3
Du Bois, A.4
Delaloye, J.F.5
Kristensen, G.B.6
-
5
-
-
70350521064
-
Pemetrexed: A review of its use in the management of advanced non-squamous non-small cell lung cancer
-
C.M. Baldwin, and C.M. Perry Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer Drugs 69 2009 2279 2302
-
(2009)
Drugs
, vol.69
, pp. 2279-2302
-
-
Baldwin, C.M.1
Perry, C.M.2
-
6
-
-
0041629528
-
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
-
DOI 10.1200/JCO.2003.11.136
-
N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, and P. Ruffie Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644 (Pubitemid 46606305)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.14
, pp. 2636-2644
-
-
Vogelzang, N.J.1
Rusthoven, J.J.2
Symanowski, J.3
Denham, C.4
Kaukel, E.5
Ruffie, P.6
Gatzemeier, U.7
Boyer, M.8
Emri, S.9
Manegold, C.10
Niyikiza, C.11
Paoletti, P.12
-
7
-
-
0030976709
-
Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines
-
DOI 10.1002/(SICI)1097-4644(19970615)65:4<479::AID-JCB4>3.0.CO;2-L
-
S. Miotti, M. Bagnoli, F. Ottone, A. Tomassetti, M.I. Colnaghi, and S. Canevari Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines J Cell Biochem 65 1997 479 491 (Pubitemid 27240914)
-
(1997)
Journal of Cellular Biochemistry
, vol.65
, Issue.4
, pp. 479-491
-
-
Miotti, S.1
Bagnoli, M.2
Ottone, F.3
Tomassetti, A.4
Colnaghi, M.I.5
Canevari, S.6
-
8
-
-
0032484540
-
Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells
-
DOI 10.1002/(SICI)1097-0215(19980105)75:1<125::AID-IJC19>3.0.CO;2-F
-
G. Corona, F. Giannini, M. Fabris, G. Toffoli, and M. Boiocchi Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells Int J Cancer 75 1998 125 133 (Pubitemid 28113987)
-
(1998)
International Journal of Cancer
, vol.75
, Issue.1
, pp. 125-133
-
-
Corona, G.1
Giannini, F.2
Fabris, M.3
Toffoli, G.4
Biocchi, M.5
-
9
-
-
34249106183
-
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer
-
DOI 10.1158/1078-0432.CCR-06-2393
-
C.H. Takimoto, L.A. Hammond-Thelin, J.E. Latz, L. Forero, M. Beeram, and B. Forouzesh Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer Clin Cancer Res 13 2007 2675 2683 (Pubitemid 46788035)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.9
, pp. 2675-2683
-
-
Takimoto, C.H.1
Hammond-Thelin, L.A.2
Latz, J.E.3
Forero, L.4
Beeram, M.5
Forouzesh, B.6
De Bono, J.7
Tolcher, A.W.8
Patnaik, A.9
Monroe, P.10
Wood, L.11
Schneck, K.B.12
Clark, R.13
Rowinsky, E.K.14
-
10
-
-
65249113396
-
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
-
I. Vergote, H. Calvert, M. Kania, C. Kaiser, A.H. Zimmermann, and J. Sehouli A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer Eur J Cancer 45 2009 1415 1423
-
(2009)
Eur J Cancer
, vol.45
, pp. 1415-1423
-
-
Vergote, I.1
Calvert, H.2
Kania, M.3
Kaiser, C.4
Zimmermann, A.H.5
Sehouli, J.6
-
11
-
-
0028053693
-
The future role of carboplatin
-
J.C. Ruckdeschel The future role of carboplatin Semin Oncol 21 5 Suppl. 12 1994 114 118 (Pubitemid 24378896)
-
(1994)
Seminars in Oncology
, vol.21
, Issue.5 SUPPL. 12
, pp. 114-118
-
-
Ruckdeschel, J.C.1
-
12
-
-
0024402541
-
Review of therapeutic trials of carboplatin in lung cancer
-
P.A. Bunn Jr. Review of therapeutic trials of carboplatin in lung cancer Semin Oncol 16 2 Suppl. 5 1989 27 33 (Pubitemid 19138343)
-
(1989)
Seminars in Oncology
, vol.16
, Issue.2 SUPPL. 5
, pp. 27-33
-
-
Bunn Jr., P.A.1
-
13
-
-
47649086616
-
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - Long-term follow-up
-
DOI 10.1111/j.1525-1438.2007.01094.x
-
B. Sorbe, H. Andersson, K. Boman, P. Rosenberg, and M. Kalling Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up Int J Gynecol Cancer 18 2008 803 808 (Pubitemid 352020182)
-
(2008)
International Journal of Gynecological Cancer
, vol.18
, Issue.4
, pp. 803-808
-
-
Sorbe, B.1
Andersson, H.2
Boman, K.3
Rosenberg, P.4
Kalling, M.5
-
14
-
-
0141688377
-
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
-
DOI 10.1200/JCO.2003.02.153
-
R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 21 2003 3194 3200 (Pubitemid 46606249)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.17
, pp. 3194-3200
-
-
Ozols, R.F.1
Bundy, B.N.2
Greer, B.E.3
Fowler, J.M.4
Clarke-Pearson, D.5
Burger, R.A.6
Mannel, R.S.7
DeGeest, K.8
Hartenbach, E.M.9
Baergen, R.10
Mackey, D.11
-
15
-
-
20244374653
-
Phase i clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
-
A. Hughes, P. Calvert, A. Azzabi, R. Plummer, R. Johnson, and J. Rusthoven Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma J Clin Oncol 20 2002 3533 3544
-
(2002)
J Clin Oncol
, vol.20
, pp. 3533-3544
-
-
Hughes, A.1
Calvert, P.2
Azzabi, A.3
Plummer, R.4
Johnson, R.5
Rusthoven, J.6
-
16
-
-
77956231005
-
A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
-
J. Sehouli, O. Camara, S. Mahner, T. Bauknecht, W. Lichtenegger, and I. Runnebaum A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer Cancer Chemother Pharmacol 66 2010 861 868
-
(2010)
Cancer Chemother Pharmacol
, vol.66
, pp. 861-868
-
-
Sehouli, J.1
Camara, O.2
Mahner, S.3
Bauknecht, T.4
Lichtenegger, W.5
Runnebaum, I.6
-
17
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Amer Stat Assoc 53 1958 457 481
-
(1958)
J Amer Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
18
-
-
77954726606
-
Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
-
E. Pujade-Lauraine, U. Wagner, E. Aavall-Lundqvist, V. Gebski, M. Heywood, and P.A. Vasey Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse J Clin Oncol 28 2010 3323 3329
-
(2010)
J Clin Oncol
, vol.28
, pp. 3323-3329
-
-
Pujade-Lauraine, E.1
Wagner, U.2
Aavall-Lundqvist, E.3
Gebski, V.4
Heywood, M.5
Vasey, P.A.6
-
19
-
-
57449098425
-
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
-
U.A. Matulonis, N.S. Horowitz, S.M. Campos, H. Lee, J. Lee, and C.N. Krasner Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer J Clin Oncol 26 2008 5761 5766
-
(2008)
J Clin Oncol
, vol.26
, pp. 5761-5766
-
-
Matulonis, U.A.1
Horowitz, N.S.2
Campos, S.M.3
Lee, H.4
Lee, J.5
Krasner, C.N.6
-
20
-
-
51349126665
-
Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): A meta-analysis of published data
-
abstr 5524
-
M. Orlando, M.V. Costanzo, R.D. Chacon, and C.D. Tajer Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC): a meta-analysis of published data J Clin Oncol 25 18S 2007 280s abstr 5524
-
(2007)
J Clin Oncol
, vol.25
, Issue.18 S
-
-
Orlando, M.1
Costanzo, M.V.2
Chacon, R.D.3
Tajer, C.D.4
-
21
-
-
18844438587
-
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer
-
DOI 10.1111/j.1525-1438.2005.15355.x
-
J. Pfisterer, I. Vergote, A. du Bois, and E. Eisenhauer Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer Int J Gynecol Cancer 15 Suppl. 1 2005 36 41 (Pubitemid 40696476)
-
(2005)
International Journal of Gynecological Cancer
, vol.15
, Issue.SUPPL. 1
, pp. 36-41
-
-
Pfisterer, J.1
Vergote, I.2
Du Bois, A.3
Eisenhauer, E.4
|